Former Surgeon General C. Everett Koop said it best: “Drugs don’t work in patients who don’t take them.” Unfortunately, many patients don’t take their drugs. Health care providers, third-party payers, and pharmaceutical companies have taken notice. They’re studying the issue of non-adherence and looking for solutions to the problem. Sharps Compliance is an active partner in this effort.Continue reading “How Sharps’ Patient Support Program Helps Improve Data Collection & Collaboration”
Beginning December 1, 2019, compounding pharmacies and other healthcare facilities that handle hazardous drugs (HD) must have USP <800> compliant spill kits on-site. This is an effort to protect workers in the event of accidental spills of HDs. The requirement is part of USP General Chapter 800, which “describes the practice and quality standards for handling hazardous drugs.” Sharps Compliance is introducing the Hazardous Drug Spill Control Kit™ for the safe cleanup and disposal of spilled chemotherapy and other hazardous drugs.Continue reading “USP <800> Compliant Hazardous Drug Spill Control Kits from Sharps Compliance”
Last fall, Congress passed the “Access to Increased Drug Disposal (AIDD) Act as part of a larger package of bills aimed at controlling the national opioid epidemic. AIDD allows states to compete for $10 million in federal grants designed to increase participation in safe medication disposal programs. Five states will be chosen to receive grant money to implement drug take back demonstration projects that encourage “authorized collectors,” such as hospitals and retail pharmacies, to increase public access to drug collection boxes.Continue reading “Federal Grant Program Encourages States to Increase Drug Take Back Efforts”
The number of Americans self-injecting drugs outside healthcare settings increases each year. A 2015 study by Zion Research estimated that the global injectable drug market will grow at a compound annual growth rate of 11.8% between 2016-2021. Many patients need to inject medications when away from home but lack access to safe disposal options.Continue reading “Safe Needle Disposal Helps Protect Public from Needlestick Injuries”
In 2017, the Food and Drug Administration (FDA) expressed concern that physicians were contributing to the opioid epidemic by over-prescribing the drugs. Recent evidence shows that doctors paid attention. In July, Blue Cross Blue Shield reported 2017 numbers showing fewer opioid prescriptions and an increase in new prescriptions meeting the Centers for Disease Control and Prevention’s chronic pain prescription guidelines.
Continue reading “New Laws and Prescription Guidelines Target Opioid Abuse Crisis”